The risks and benefits of using and continuing adjuvant therapies is often debated for many cancer types. In this session, Dr Anwaar Saeed from University of Kansas Cancer Center discusses the use of adjuvant therapy for esophageal cancer and the value of complete versus partial or non-response to treatment.
To obtain credit for this CME activity you must watch the full 2022 Evolution Conference Playlist. Information on obtaining CME/CE Credits and MOC points can be found in the playlist description.